Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19ARF) and is amplified in a subset of human breast cancers

Jacqueline J.L. Jacobs , Petra Keblusek , Els Robanus-Maandag , Petra Kristel , Merel Lingbeek , Petra M. Nederlof , Tibor van Welsem , Marc J. van de Vijver , Eugene Y. Koh , George Q. Daley & Maarten van Lohuizen

To read this article in full you may need to log in, make a payment or gain access through a site license (see right).